Immuneering Corporation (IMRX)
NASDAQ
Quarter End | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 | 9 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||||
総売上 | 1,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
営業利益 | -13.99M | -14.68M | -13.51M | -13.93M | -16.3M | -15.33M | -14.91M | -15.27M |
税引前収入 | -13.25M | -13.6M | -12.19M | -12.6M | -15.08M | -14.31M | -14.08M | -14.6M |
純利益 | -13.25M | -13.6M | -12.19M | -12.6M | -15.08M | -14.31M | -14.08M | -14.6M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -13.77M | -14.44M | -13.36M | -13.45M | -15.84M | -15.11M | -14.91M | -15.14M |
EBITDA | -13.9M | -14.6M | -13.42M | -13.84M | -16.21M | -15.23M | -14.82M | -15.18M |
年末 2023年12月31日 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 1.92M | 2.31M | 2.08M | 317k | 0 |
営業利益 | -6.29M | -17.08M | -33.89M | -51.75M | -58.41M |
税引前収入 | -7.71M | -17.04M | -33.84M | -50.51M | -53.47M |
純利益 | -7.71M | -17.04M | -33.54M | -50.51M | -53.47M |
優先配当 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | -0.65 | -1.064 | -0.548 | -0.823 | -0.797 |
EBIT | -7.42M | -17.08M | -34.01M | -51.53M | -57.08M |
EBITDA | -6.27M | -17.06M | -33.84M | -51.47M | -58.06M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約